Research has shown that the NF-κB signaling pathway is crucial in inducing pro-inflammatory gene expression, regulating inflammasome, activating inflammatory T lymphocytes, and innate immune cell differentiation in IBD patients. This evidence concerns the gene NFKB1 and inflammatory bowel disease.